Insider: COATS LONNEL Chief Executive Officer - LEXICON PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 914,359 | 0 | 914,359 |
| Value | $1,280,102.60 | $0.00 | $1,280,102.60 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/16/2023 | AAP | 90,000 | Direct | COM | $1.05 | $94,797.00 | 914,359 |
| 11/10/2023 | AAP | 10,000 | Direct | COM | $1.01 | $10,100.00 | 824,359 |
| 06/29/2023 | AAP | 10,000 | Direct | COM | $2.16 | $21,600.00 | 814,359 |
| 06/26/2023 | AAP | 10,000 | Direct | COM | $2.18 | $21,792.00 | 804,359 |
| 06/23/2023 | AAP | 10,000 | Direct | COM | $2.50 | $24,950.00 | 794,359 |
| 06/22/2023 | AAP | 40,000 | Direct | COM | $2.31 | $92,400.00 | 784,359 |
| 09/18/2019 | AAP | 50,000 | Direct | COM | $3.10 | $155,000.00 | 227,539 |
| 09/17/2019 | AAP | 100 | Direct | COM | $3.13 | $312.50 | 127,639 |
| 09/17/2019 | AAP | 3,000 | Direct | COM | $3.12 | $9,357.00 | 130,639 |
| 09/17/2019 | AAP | 40,290 | Direct | COM | $3.13 | $126,107.70 | 177,539 |
| 09/17/2019 | AAP | 277 | Direct | COM | $3.13 | $866.90 | 137,249 |
| 09/17/2019 | AAP | 6,333 | Direct | COM | $3.12 | $19,758.96 | 136,972 |
| 08/19/2019 | AAP | 3,000 | Direct | COM | $1.40 | $4,194.00 | 127,539 |
| 08/16/2019 | AAP | 10,044 | Direct | COM | $1.33 | $13,358.52 | 97,739 |
| 08/16/2019 | AAP | 156 | Direct | COM | $1.33 | $206.70 | 87,695 |
| 08/16/2019 | AAP | 100 | Direct | COM | $1.34 | $133.50 | 97,839 |
| 08/16/2019 | AAP | 6,600 | Direct | COM | $1.34 | $8,844.00 | 104,439 |
| 08/16/2019 | AAP | 3,500 | Direct | COM | $1.35 | $4,725.00 | 108,539 |
| 08/16/2019 | AAP | 600 | Direct | COM | $1.35 | $807.00 | 105,039 |
| 08/16/2019 | AAP | 16,000 | Direct | COM | $1.36 | $21,760.00 | 124,539 |
| 11/15/2017 | AAP | 10,000 | Direct | COM | $9.91 | $99,100.00 | 42,985 |
| 09/15/2017 | AAP | 2,400 | Direct | COM | $12.55 | $30,120.00 | 22,385 |
| 09/15/2017 | AAP | 1,951 | Direct | COM | $12.56 | $24,504.56 | 24,336 |
| 09/15/2017 | AAP | 400 | Direct | COM | $12.54 | $5,014.00 | 19,985 |
| 09/15/2017 | AAP | 600 | Direct | COM | $12.52 | $7,509.96 | 26,936 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research